UK shareholder meetings calendar - next 7 days
22nd Jun 2023 15:44
MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says its investigational medicinal product, CannEpil, has been successfully delivered to its first UK patients through I Am Billy Foundation. Says CannEpil also has been delivered to its first patient in the UK through a named patient request programme. Read More
MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Says Brett Mitchell and Nativ Segev, will step down from the board, reflecting the changing direction of the company as it moves away from the medicinal cannabis sector toward a more pharma-focused business strategy. Stephen Parker, currently non-executive director, will replace Mitchell as interim non-executive chair. A new Australian non-executive director will also be appointed. Appoints Oberon Capital as joint broker in the UK with immediate effect alongside Peterhouse Capital. Read More
MGC Pharmaceuticals Ltd - London-based pharmaceutical company specialising in plant-inspired medicines - Raises GBP2.1 million via a fundraising announced on Tuesday, which has now closed. Shares issued under the placing will be admitted to London Stock Exchange on April 18. In addition, MGC secures GBP256,590 in a separate offer to Australian and UK high-net-worth investors. Read More
MGC Pharmaceuticals Ltd - Perth, Australia-based pharmaceutical company specialising in plant-inspired medicines - Says its investigational medicinal product CannEpil for patients suffering from refractory epilepsy is now available in the UK by named patient request to be prescribed by doctors. The product is now in the process of a clinical development programme. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday not separately reported by Alliance News: Read More
(Alliance News) - MGC Pharmaceuticals Ltd on Tuesday said its ArtemiC product has now been listed as an over-the-counter, non-prescription drug in the US, while its supply and distribution partner AMC Holdings Inc has placed a USD2 million order. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Tuesday not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - MGC Pharmaceuticals Ltd on Friday said it received USD600,000 in funding provided by Mercer Street Capital Partners LLC, while it has appointed a new chief financial officer. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Corrects that Zenith Energy is based in Canada, not in Scotland.) Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Secures AUD800,000 in funding under USD10 million convertible securities financing facility agreement signed with Mercer Street Global Opportunity Fund LLC, a fund managed by Mercer Street Capital Partners. Under the terms of the facility, MGC will issue Mercer 586,432 convertible notes with a face value of USD1.0 each. The company said the funding will be used as working capital for "ongoing operations", including its clinical trials programme. Read More
MGC Pharmaceuticals Ltd - Perth, Australia-based medicinal cannabis company - Completes the delivery of its "largest" order of ArtemiC Rescue to US distribution and marketing partner, AMC Holdings Inc. Says the order is worth USD1.0 million and was delivered in a single shipment. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More